Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Jefferson and Michigan Scientists Identify Gene Defect Behind Muscle-Wasting Disease

13.10.2003


Insights gained from extensive studies in mice may someday lead to treatments for comparable neurodegenerative diseases in humans



Scientists at Jefferson Medical College and the University of Michigan have uncovered a gene defect responsible for a muscle-wasting, neurodegenerative disease in mice known as mnd2. Their results may provide insights into the molecular origins of other such diseases in humans, including Parkinson’s disease.

In an online report on October 8 in the journal Nature, the researchers, led by Emad Alnemri, Ph.D., at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and Miriam Meisler, Ph.D., at the University of Michigan in Ann Arbor, showed that a mutation in a single amino acid in the protein Omi/HtrA2 is enough to cause the neuromuscular disease. In mnd2 mice, the amino acid serine is changed to cysteine.


Michigan senior research associate Julie Jones, a member of Dr. Meisler’s research team, discovered the mnd2 mouse model, an inherited neurological disease, in 1990. mnd2 is characterized by an abnormal gait, muscle wasting and early death. To identify the guilty gene, Dr. Meisler’s laboratory used a technique called positional cloning, eventually narrowing the mutation to a small region containing six candidate genes on chromosome 6. To find the specific genetic defect, they determined the nucleotide sequence of these candidate genes and discovered that the mnd2 defect was caused by a “point” mutation in the Omi gene.

Dr. Alnemri had been studying the Omi/HtrA2 protease – an enzyme that cleaves proteins – and its role in programmed cell death. When he located the Omi gene on chromosome 2p13.1 – which happened to correspond to mouse chromosome 6, where the mnd2 locus is found – he suspected that a mutation in the Omi/HtrA2 gene could be behind the mnd2 disease. According to Dr. Alnemri, who is professor of microbiology and immunology at Jefferson Medical College and a member of Jefferson’s Kimmel Cancer Center, Omi/HtrA2 is present in the mitochondria, which generates energy in the cell. Omi regulates apoptosis, or programmed cell death, by binding and cleaving proteins that block the process. He and his co-workers at Jefferson characterized the mutation and discovered that it causes a loss of proteolytic activity of the protein, though the mutant protease can still bind to apoptosis-blocking proteins.

The Jefferson team performed additional tests on both normal and mutant mice cells, revealing that the cells from mutant mice were more sensitive to cellular stresses. They also discovered that mitochondria are defective in these cells as well. “The normal protease helps maintain normal mitochondrial function and is important for maintaining survival of cells in the nervous system,” says Dr. Alnemri.

The finding was surprising, says Dr. Meisler, a professor in the Department of Human Genetics at Michigan, because “Omi had not been thought to be involved in neurological disease. It appears to cause neuronal cell death by impairment of mitochondrial function.” “Interestingly, that same chromosome region in humans has been mapped in certain patients with Parkinson’s disease,” Dr. Alnemri notes. “We tested a few of these Parkinson’s samples but we did not find mutations in Omi. We still don’t know if this gene is mutated in other types of Parkinson’s or different neurodegenerative disorders.”

“Based on the severe neurodegeneration and muscle wasting in the mnd2 mouse, we will now begin to screen DNA samples from patients with related disorders in order to determine the medical impact of mutations in this gene,” says Dr. Meisler. “The prospects for treatment will be improved by accurate diagnosis in affected patients. We will extend the mutation search to the human gene, in order to determine its role in neuromuscular diseases.”

The Omi protein and related proteins are found in all organisms, including bacteria. In the latter, Omi-related proteins function as “molecular sensors” of cellular stresses, Dr. Alnemri says.

“Our next step is to find out whether Omi in humans functions as a sensor of mitochondrial stress and to understand at the molecular level how Omi regulates mitochondrial function,” he says.

Steven Benowitz | TJUH
Further information:
http://www.jeffersonhospital.org/news/e3front.dll?durki=17158

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>